Luo W T, Zheng X H, Zhang J L, Sun B Q
Department of Clinical Laboratory of the First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou 510120, China.
Zhonghua Yu Fang Yi Xue Za Zhi. 2024 Feb 6;58(2):268-274. doi: 10.3760/cma.j.cn112150-20231219-00463.
With the increasing global prevalence of tree pollen allergies, there has been a significant impact on the quality of life for populations. In North and Central China, birch pollen, cypress pollen, and plane tree pollen are the most common allergens for springtime pollen allergy sufferers. The distribution of plants and patterns of pollen transmission in different geographical areas result in varying pollen exposure outcomes, further complicating the challenges in diagnosis and individualized treatment. This article delves into the research progress and clinical application of tree pollen allergies based on the "Molecular Allergology User's Guide 2.0 (MAUG 2.0) " published by the European Academy of Allergy and Clinical Immunology (EAACI). It discusses major allergen families and component proteins of tree pollen such as PR-10 proteins, profilins, polcalcins, as well as cross-reactive components that may cause pollen-food allergy syndrome. Allergen component diagnostics can distinguish true allergy sufferers from those with multiple allergen reactions, enabling more targeted selection of allergens for specific immunotherapy, thus enhancing treatment effectiveness. Bet v 1 and Cup a 1, for instance, are specific indicators for immunotherapy in birch and cypress allergy patients. Overall, this article provides cutting-edge information for professionals in the field of tree pollen allergies, offering in-depth exploration of tree pollen allergen component proteins, clinical manifestations, and treatment-related research, aiding in better understanding and addressing the challenges of tree pollen allergies.
随着全球树木花粉过敏患病率的不断上升,对人群的生活质量产生了重大影响。在中国北方和中部地区,桦树花粉、柏树花粉和悬铃木花粉是春季花粉过敏患者最常见的过敏原。不同地理区域植物的分布和花粉传播模式导致花粉暴露结果各异,这进一步加剧了诊断和个体化治疗的挑战。本文基于欧洲变态反应和临床免疫学会(EAACI)发布的《分子变态反应学用户指南2.0(MAUG 2.0)》,深入探讨了树木花粉过敏的研究进展和临床应用。它讨论了树木花粉的主要过敏原家族和组成蛋白,如PR-10蛋白、肌动蛋白结合蛋白、钙结合蛋白,以及可能导致花粉-食物过敏综合征的交叉反应成分。过敏原成分诊断可以区分真正的过敏患者和有多种过敏原反应的患者,从而能够更有针对性地选择用于特异性免疫治疗的过敏原,提高治疗效果。例如,Bet v 1和Cup a 1是桦树和柏树过敏患者免疫治疗的特异性指标。总体而言,本文为树木花粉过敏领域的专业人员提供了前沿信息,对树木花粉过敏原组成蛋白、临床表现及治疗相关研究进行了深入探讨,有助于更好地理解和应对树木花粉过敏带来的挑战。